[CT-guided punctures: diagnostic value, therapeutic consequences and economic aspects]

Diagnostic procedures often face a balance between accuracy and cost. Prior research has shown that imaging techniques like CT scans are widely used for diagnosis. However, the economic impact of these procedures remains unclear in many cases. Established knowledge includes the use of CT-guided biopsies for tumor detection. Yet, the extent to which these procedures reduce unnecessary surgeries is less understood. This gap motivated an investigation into the clinical and economic outcomes of CT-guided biopsies. That uncertainty drove the need to analyze both diagnostic accuracy and cost implications. No prior work had resolved how early biopsies might reduce hospital stays. This study aimed to address that gap by evaluating a large cohort of patients.

The aim of this study was to assess the diagnostic accuracy, clinical impact, and cost implications of CT-guided biopsies. The specific problem addressed was whether these procedures could avoid unnecessary surgeries and diagnostics. The motivation stemmed from the need to optimize healthcare resource use. The researchers proposed to evaluate biopsy outcomes in a real-world clinical setting. The study focused on patients referred for tumor and metastasis evaluation. The goal was to determine how often biopsies changed clinical management. The authors also sought to quantify the economic benefits of early biopsy use. Their hypothesis centered on the potential for cost savings through reduced hospital stays.

The study design involved a retrospective analysis of 213 CT-guided biopsies performed on 190 patients. The researchers collected data on patient referrals, biopsy reasons, and body regions involved. They tracked clinical outcomes and economic consequences over an average of 22.2 months. The primary data sources were medical records and follow-up reports. The analysis included comparisons between biopsy and surgical histology results. The team categorized diagnostic outcomes into benign and malignant groups. They also measured the frequency of follow-up studies and surgical interventions. The study used descriptive statistics to summarize clinical and economic findings.

The strongest finding was that 73% of CT-guided biopsies matched surgical histology results. Biopsy results led to no further procedures in 22.5% of cases. Follow-up studies or conservative treatment were needed in 11.3% of patients. Only 15.5% required surgical intervention after biopsy results. The most common diagnostic outcome was benign or unspecific tissue in 24% of cases. The lung and abdomen were the most frequent biopsy sites at 39% and 35%, respectively. Outpatient procedures were rare, with less than 5% performed outside the hospital. The complication rate was low, with only one case requiring therapy.

The authors stated that CT-guided biopsy is a safe and effective diagnostic tool. They proposed that these procedures help avoid unnecessary surgeries and diagnostics. The study showed that early biopsies can reduce hospital stays and associated costs. The researchers emphasized the importance of outpatient use for cost savings. They noted that benign findings occurred in nearly a quarter of cases. The findings suggest that CT-guided biopsy is valuable in clinical decision-making. The authors concluded that this procedure supports efficient resource use in healthcare. Their claims were based on observed reductions in surgical interventions and hospitalization.